Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Morin

Showing results (451-460 of 512) with videos related to

Pageof 52
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastomaOlena Morozova, Milijana Vojvodic, Natalie Grinshtein, et al.
The Journal of Pathology|February 26, 2015
Recurrent genomic rearrangements in primary testicular lymphomaDavid D W Twa, Anja Mottok, Fong Chun Chan, et al.
Nature Communications|July 9, 2020
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasmsFerran Nadeu, Rut Mas-de-Les-Valls, Alba Navarro, et al.
Oncoimmunology|August 17, 2017
Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphomaJulie S Nielsen, Andrew R Chang, Darin A Wick, et al.
JCO Precision Oncology|September 11, 2020
Temporal Dynamics of Genomic Alterations in a <i>BRCA1</i> Germline-Mutated Pancreatic Cancer With Low Genomic Instability Burden but Exceptional Response to Fluorouracil, Oxaliplatin, Leucovorin, and IrinotecanHui-Li Wong, Eric Y Zhao, Martin R Jones, et al.
International Journal of Hematology|January 29, 2024
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironmentAlexandre Benoit, Madelyn J Abraham, Sheena Li, et al.
Blood|March 30, 2017
Genetic profiling of <i>MYC</i> and <i>BCL2</i> in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impactDaisuke Ennishi, Anja Mottok, Susana Ben-Neriah, et al.
Cancer Research|October 2, 2010
Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosisK-John J Cheung, Nathalie A Johnson, Joslynn G Affleck, et al.
Blood|November 15, 2014
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroupFong Chun Chan, Adele Telenius, Shannon Healy, et al.
Blood|April 21, 2023
Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patternsKostiantyn Dreval, Laura K Hilton, Manuela Cruz, et al.
Pageof 52

Showing results (451-460 of 512) with videos related to

Sort By:
Pageof 52
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2010
System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastomaOlena Morozova, Milijana Vojvodic, Natalie Grinshtein, et al.
The Journal of Pathology|February 26, 2015
Recurrent genomic rearrangements in primary testicular lymphomaDavid D W Twa, Anja Mottok, Fong Chun Chan, et al.
Nature Communications|July 9, 2020
IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasmsFerran Nadeu, Rut Mas-de-Les-Valls, Alba Navarro, et al.
Oncoimmunology|August 17, 2017
Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphomaJulie S Nielsen, Andrew R Chang, Darin A Wick, et al.
JCO Precision Oncology|September 11, 2020
Temporal Dynamics of Genomic Alterations in a <i>BRCA1</i> Germline-Mutated Pancreatic Cancer With Low Genomic Instability Burden but Exceptional Response to Fluorouracil, Oxaliplatin, Leucovorin, and IrinotecanHui-Li Wong, Eric Y Zhao, Martin R Jones, et al.
International Journal of Hematology|January 29, 2024
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironmentAlexandre Benoit, Madelyn J Abraham, Sheena Li, et al.
Blood|March 30, 2017
Genetic profiling of <i>MYC</i> and <i>BCL2</i> in diffuse large B-cell lymphoma determines cell-of-origin-specific clinical impactDaisuke Ennishi, Anja Mottok, Susana Ben-Neriah, et al.
Cancer Research|October 2, 2010
Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosisK-John J Cheung, Nathalie A Johnson, Joslynn G Affleck, et al.
Blood|November 15, 2014
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroupFong Chun Chan, Adele Telenius, Shannon Healy, et al.
Blood|April 21, 2023
Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patternsKostiantyn Dreval, Laura K Hilton, Manuela Cruz, et al.
Pageof 52